Erwin van Wijk (born in 1975) is an Associate Professor at the Department of Otorhinolaryngology of Radboudumc, Nijmegen, The Netherlands. He heads a research team dedicated to develop new antisense oligonucleotide-based splice modulation therapies for Usher Syndrome, using zebrafish as an animal. His team obtained pre-clinical therapeutic proof of concept for multiple USH2A targets using this approach. One of the molecules has already been evaluated in a phase I/II clinical trial, with promising outcomes. At the moment, his team is also working on the phenotypic analysis and development of innovative treatments for other types of Usher syndrome.